gestational diabetes mellitus
Conditions
Interventions
Insulin injection group :Blood glucose management was accomplished with subcutaneous injections of rapid-acting insulin, including NovoRapid (FlexPen NO.S20217021) and Levemir (FlexPen NO.S20217014).
Double "C" group:An insulin pump (Model: TruCare II) was used for NovoRapid (Penfill No. S20153001) administration. The regimen was: a continuous infusion of NovoRapid at 0.4-0.5 U/(kg-d) was delivere
Sponsors
Jiangxi Maternal and Child Health Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) Patients with poor blood sugar control after diet guidance and appropriate exercise were hospitalized to receive intensive insulin pump therapy; (2) This study was approved by the Medical Ethics Committee of our hospital, and all patients understood the basic matters of this study, voluntarily participated in it and signed written informed consent; (3) Good compliance.
Exclusion criteria
Exclusion criteria: Patients with anemia; Diabetic patients before pregnancy; Patients with a genetic history of diabetes; Patients with abnormal liver and kidney function; People with communication or communication difficulties; Patients with insulin allergic reaction; Patients with chronic infectious diseases; Before and during pregnancy, no drugs or health products have been taken that have an impact on the body's sugar metabolism.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FBG; | — |
Countries
China
Contacts
Public Contactshixiling
Jiangxi Maternal and Child Health Hospital
Outcome results
None listed